List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
EGD-EC-003A phase IIIb randomized study of intermittent versus continuous androgen deprivation therapy using ELIGARD 22.5 mg 3-month depot in patients with relapsing or locally advanced prostate cancer who are responsive to such therapy English


English


EGD-EC-005An exploratory, open label, single-arm study to evaluate the effect of Eligard® 6-month on biomarkers of disease in patients with metastatic prostate cancer English


English


QUICK SEARCH

USEFUL LINKS